'got breakfast?'(TM) Foundation Issues Statement on Recently Released Florida State Plan of Action from the Governor's Council on Physic... (rg target

(Date:12/1/2008)...wire-USNewswire/ -- Democratic National Committee ...atement commemorating World AIDS Day on its 20th A...com/cgi-bin/prnh/20080519/DNCLOGO ) , , "It...nd while we have made strides, much work remains t...onal and global strategy. We must focus not only ...

(Date:12/1/2008)... MassMutual Retirement Services Di...s increasing nonprofit business. Nonprofit activit...ear. , , Dan Darby joined MassMutual on De...stern region. He reports to M. Palmer Whitney, nat...sMutual,s Retirement Services Division, who will c...

(Date:12/1/2008)...ents can also trigger acute organ failure, study s...-- Antibiotics are the single largest class of dru...ury (DILI), researchers say. , The condition ac...r failure in the United States and is the most com...DILI is caused by a wide range of prescription and...

(Date:12/1/2008)...disorder (PTSD) affects as many as one in five of ...ike rape, assault, war or terrorism. It has emotio...rvivors, families. , There is no broadly accept...ng the disorder, but thanks to a Tel Aviv Universi...may be just around the corner. , Prof. Joseph Zo...

Breaking Medicine News(10 mins):Health News:MassMutual Retirement Services Adds Two to Nonprofit Sales Team 2 Health News:MassMutual Retirement Services Adds Two to Nonprofit Sales Team 3 Health News:Antibiotics Largest Cause of Drug-Induced Liver Damage 2 Health News:Easing the stress of trauma 2

[0] Statement of DNC Chairman Howard Dean on World AIDS Day [0] MassMutual Retirement Services Adds Two to Nonprofit Sales Team [0] Antibiotics Largest Cause of Drug-Induced Liver Damage [0] Easing the stress of trauma

... of stress,a self-perpetuating cycle of factors ca...esulting weight gain often piles up around the abd...troke.This applies to both sexes.// One doctor sta...d the hazards of weight gain in midlife by learnin...

... inactivation of nitric oxide, a hormone involved ...m. If high blood pressure is left untreated, it do...iral out of control. According to the researchers ...ted on rats and found that nitric oxide, which hel...

...ltry number of human genes more than 30 per cent h... from the human genome sequence seemed scanty comp...tfly's (13,000). Michael Cooke and colleagues at t...undation in San Diego, California compared the two...

...r from lack of proper nutrition while pregnant may...earchers have found. A team from the University o... who were conceived during the Dutch famine of 194...azi occupation.// They found that the rate of obe...

Other Medicine News:

Stress can make you overweight Nitric oxide involved in high blood pressure Human gene number increases Starving leads to obesity

(Date:11/25/2008)...ov. 25 Poniard,Pharmace...al company focused on,innovative oncology therapi...ategic alternatives for its preclinical research p...s resources on the clinical development of picopla...he initial commercialization of,picoplatin in the...

(Date:11/25/2008)...-FirstCall/ -- CardioVascular,BioTherapeutics, In...t it has,dosed the first patient in North America...l to treat patients with severe coronary heart dis...f CORonary heart Disease) trial will include,four...s in approximately 120,patients with severe coron...

(Date:11/24/2008)...ewswire-FirstCall/ -- Leaders of Schering-Plough C... for investors on the company,s research pipeline,... includes 46 new entities in clinical trials or un...s. , , "Research and development is adding ...inue our transformation," said Fred Hassan, chairm...

(Date:11/24/2008)... Unveils Rich Development Pipeline of Compounds Me...H, N.J., Nov. 24 Scherin... top-line results of a long-term Phase III clinica...M) (asenapine) demonstrating efficacy and safety i...ial, asenapine was statistically significantly mor...

Breaking Medicine Technology:Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2 Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3 CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2 CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3 Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2 Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3 Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4 Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5 Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention 2 Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention 3 Type 1 diabetes triggered by lazy regulatory T cells 3A McGill researchers 1903 1 Type 1 diabetes triggered by lazy regulatory T cells 3A McGill researchers 1903 2 Prominent Health Care Executive Kevin Kraushaar Joins Triadvocates LLC as Managing Principal of DC Office 9562 1 Prominent Health Care Executive Kevin Kraushaar Joins Triadvocates LLC as Managing Principal of DC Office 9562 2 Prominent Health Care Executive Kevin Kraushaar Joins Triadvocates LLC as Managing Principal of DC Office 9562 3 Virginia Cares Uninsured Program 28VCUP 29 Announces Early Successes in Helping Uninsured Virginians Access Quality Healthcare 9559 1 Virginia Cares Uninsured Program 28VCUP 29 Announces Early Successes in Helping Uninsured Virginians Access Quality Healthcare 9559 2 Virginia Cares Uninsured Program 28VCUP 29 Announces Early Successes in Helping Uninsured Virginians Access Quality Healthcare 9559 3 Health Options Inc s BlueMedicare HMO Earns NCQA Excellent Rating 9556 1 Health Options Inc s BlueMedicare HMO Earns NCQA Excellent Rating 9556 2

[0] Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin [0] CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease [2] Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects [0] Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention

...ER, Mass., Jun 27, 2007 (PrimeNewswire via COMTEX ... (Nasdaq:GNBT), the,leader in drug delivery for me...outh, announced today that it will be making three...f the European,Society of Pediatric Endocrinology ...t="_blank" href=,"http://www.espe2007.org/">www.es...

..., Ore.--(BUSINESS WIRE)--Jul 10, 2007 - AVI BioPha...artner Cook Medical has,completed target patient e...om a Phase II clinical trial known as Appraisal.,T...igned to study,the effect of the Neugene(R) antise...ith the placement of one or more bare metal,stents...

Other Medicine Technology:Generex Biotechnology to Make Presentations At 46th Annual Meeting,of the European Society of Pediatric Endocrinology 2 Generex Biotechnology to Make Presentations At 46th Annual Meeting,of the European Society of Pediatric Endocrinology 3 AVI BioPharma Partner Cook Medical Announces Completion of Patient,Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of,Cardiovascular Disease 2

Generex Biotechnology to Make Presentations At 46th Annual Meeting,of the European Society of Pediatric Endocrinology AVI BioPharma Partner Cook Medical Announces Completion of Patient,Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of,Cardiovascular Disease

The e.cam single-detector system offers general purpose scanning flexibility with unrestricted access for gurneys and wheelchairs. This cost-effective system features a clinically versatile open gant

In Stainless steel. Available in 1.5, 2.0,3.0 & 3.5 MM

Spring Type with lock. Titanium.

The REVEALRT and REVEALXVI PET/CT scanners combine our fastest PET scanner, the REVEALXL, with multi-slice spiral CT scanners from Siemens Medical Systems.

Medicine Products:

e.cam Single Chalazion Curette Blade Holder Reveal XVI

'got breakfast?'(TM) Foundation Issues Statement on Recently Released Florida State Plan of Action from the Governor's Council on Physic...(rg target _new http://www.gotbreakfast....),Health